Pharmaceutical Sector Q2 report .Iran-2015
General Overview of the Iran Economy and the Pharmaceutical Sector 2015
- Macroeconomic Overview of Iran
- Global Pharmaceutical Sector
- History of the Pharmaceutical Sector in Iran
- Overview of the Pharmaceutical Sector in Iran
- FDO Regulation in Iran
Day holding's Risk/Reward Rating (RRR) tool, which provides global comparison and a numerically based assessment of a market's attractiveness, was established to asses the risks and rewards of middle east countries in the pharmaceutical sector. Iran's pharmaceutical Risk/Reward Rating (RRR) score for the 2nd quarter of 2015 was 68 points. Consequently, Iran takes 5th place among 20 markets which have been surveyed in Middle-east and CIS countries for pharmaceuticals .Iran's large drug market, coupled with the sector's long-term growth potential, enabled the country to score relatively well for rewards.
For more information please contact : [email protected]